Cost-effectiveness of Infloran (TM) in Treating Acute Childhood Diarrhea in Phramongkutklao Hospital (infloran)

Phramongkutklao College of Medicine and Hospital

Status: Unknown

Conditions: Acute Diarrhea

Treatments: Drug: Probiotic - Infloran

Study type: Interventional

Funder types: Other

Identifiers

NCT01273012

P001h/53

Details and patient eligibility

About

The purpose of this study is to determine whether the probiotic Infloran is cost-effective in treating acute childhood diarrhea.

Full description

Probiotics have been proved to shorten duration of diarrhea in children; whether they are cost-effective is less clear. We'd like to validate the use of Infloran, a proprietary probiotic sold in Thailand, in terms of its cost-effectiveness compared to standard diarrhea care in our hospital setting.

Enrollment: 128 estimated patients

Sex: All

Ages: 3 months to 6 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children 3 months to 6 years of age
• Hospitalized due to acute diarrhea

Exclusion criteria

• History of probiotic treatment in this episode of illness
• History of use of other anti-diarrheal medications
• Chronic gastrointestinal disease(s)
• Severe dehydration
• Severe systemic disease(s)

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

128 participants in 2 patient groups, including a placebo group

Placebo

Placebo Comparator group

Description:

The group of patients treated with placebo.

Treatment:

Drug: Probiotic - Infloran

Infloran

Experimental group

Description:

The group of patients treated with Infloran.

Treatment:

Drug: Probiotic - Infloran